Innovative health policy research and economic analysis for Influencing policy debates on critical healthcare issues
more
Extracting the most critical Insight elements from real-world evidence to establish value positioning and inform global market access strategies
more
Advancing payer marketing through experiential strategy, effective value demonstration, and market access-focused resource development
more
Positioning disruptive medical Innovations to KOLs, providers, and patients with rigorous science, data, and messaging
more
The Appeal of Value Assessment at ISPOR 2018
At this year’s ISPOR, Precision Xtract’s Larry Blandford and Precision Health Economics’ Jason Shafrin met with BioPharm Insights to illuminate the importance of shifting to value-based assessment and examine reasons why US payers are slow to adopt the model.
To read the full article, please click below.